Dose-dependent efficacy of daratumumab (DARA) as monotherapy in patients with relapsed or refractory multiple myeloma (RR MM)

Henk Lokhorst; Jacob Laubach; Hareth Nahi; Torben Plesner; Peter Gimsing; Markus Hansson; Monique Minnema; Ulrik Lassen; Jakub Krejcik; Tahamtan  Ahmadi; Imran Khan; Clarissa Uhlar; Steen Lisby; Linda Basse; Nikolai C. Brun; Paul Richardson

Dose-dependent efficacy of daratumumab (DARA) as monotherapy in patients with relapsed or refractory multiple myeloma (RR MM)

Henk Lokhorst
, Jacob Laubach
, Hareth Nahi
, Torben Plesner
, Peter Gimsing
, Markus Hansson
, Monique Minnema
, Ulrik Lassen
, Jakub Krejcik
, Tahamtan Ahmadi
, Imran Khan
, Clarissa Uhlar
, Steen Lisby
, Linda Basse
, Nikolai C. Brun
, Paul Richardson

University Medical Center Utrecht
Rigshospitalet
Genmab A/S
Dana–Farber Cancer Institute

Research output: Contribution to conference without publisher/journal › Conference abstract for conference › Research › peer-review

Original language	English
Publication date	2014
Publication status	Published - 2014
Event	Annual Congress of the European Hematology Association - Milano, Italy Duration: 12. Jun 2014 → 15. Jun 2014 Conference number: 19

Conference

Conference	Annual Congress of the European Hematology Association
Number	19
Country/Territory	Italy
City	Milano
Period	12/06/2014 → 15/06/2014

SDU Link

Check access to the material in SDU Library's search engine

Cite this

Lokhorst, H., Laubach, J., Nahi, H., Plesner, T., Gimsing, P., Hansson, M., Minnema, M., Lassen, U., Krejcik, J., Ahmadi, T., Khan, I., Uhlar, C., Lisby, S., Basse, L., C. Brun, N., & Richardson, P. (2014). Dose-dependent efficacy of daratumumab (DARA) as monotherapy in patients with relapsed or refractory multiple myeloma (RR MM). Abstract from Annual Congress of the European Hematology Association, Milano, Italy.

@conference{732c79a91626432ba2e30b8aeda296e1,

title = "Dose-dependent efficacy of daratumumab (DARA) as monotherapy in patients with relapsed or refractory multiple myeloma (RR MM)",

author = "Henk Lokhorst and Jacob Laubach and Hareth Nahi and Torben Plesner and Peter Gimsing and Markus Hansson and Monique Minnema and Ulrik Lassen and Jakub Krejcik and Tahamtan Ahmadi and Imran Khan and Clarissa Uhlar and Steen Lisby and Linda Basse and \{C. Brun\}, Nikolai and Paul Richardson",

year = "2014",

language = "English",

note = "Annual Congress of the European Hematology Association ; Conference date: 12-06-2014 Through 15-06-2014",

}

Lokhorst, H, Laubach, J, Nahi, H, Plesner, T, Gimsing, P, Hansson, M, Minnema, M, Lassen, U, Krejcik, J, Ahmadi, T, Khan, I, Uhlar, C, Lisby, S, Basse, L, C. Brun, N & Richardson, P 2014, 'Dose-dependent efficacy of daratumumab (DARA) as monotherapy in patients with relapsed or refractory multiple myeloma (RR MM)', Annual Congress of the European Hematology Association, Milano, Italy, 12/06/2014 - 15/06/2014.

Dose-dependent efficacy of daratumumab (DARA) as monotherapy in patients with relapsed or refractory multiple myeloma (RR MM). / Lokhorst, Henk; Laubach, Jacob; Nahi, Hareth et al.
2014. Abstract from Annual Congress of the European Hematology Association, Milano, Italy.

Research output: Contribution to conference without publisher/journal › Conference abstract for conference › Research › peer-review

TY - ABST

T1 - Dose-dependent efficacy of daratumumab (DARA) as monotherapy in patients with relapsed or refractory multiple myeloma (RR MM)

AU - Lokhorst, Henk

AU - Laubach, Jacob

AU - Nahi, Hareth

AU - Plesner, Torben

AU - Gimsing, Peter

AU - Hansson, Markus

AU - Minnema, Monique

AU - Lassen, Ulrik

AU - Krejcik, Jakub

AU - Ahmadi, Tahamtan

AU - Khan, Imran

AU - Uhlar, Clarissa

AU - Lisby, Steen

AU - Basse, Linda

AU - C. Brun, Nikolai

AU - Richardson, Paul

N1 - Conference code: 19

PY - 2014

Y1 - 2014

M3 - Conference abstract for conference

T2 - Annual Congress of the European Hematology Association

Y2 - 12 June 2014 through 15 June 2014

ER -